Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi

suck pdf from helios

10.1515/cclm-2020-0188

http://scihub22266oqcxt.onion/10.1515/cclm-2020-0188
suck pdf from google scholar
32172226!ä!32172226
PDF vom PMID32172226  :  Publisher

suck abstract from ncbi

pmid32172226
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Prominent changes in blood coagulation of patients with SARS-CoV-2 infection #MMPMID32172226
  • Han H; Yang L; Liu R; Liu F; Wu KL; Li J; Liu XH; Zhu CL
  • Clin Chem Lab Med 2020[Jun]; 58 (7): 1116-1120 PMID32172226show ga
  • Background As the number of patients increases, there is a growing understanding of the form of pneumonia sustained by the 2019 novel coronavirus (SARS-CoV-2), which has caused an outbreak in China. Up to now, clinical features and treatment of patients infected with SARS-CoV-2 have been reported in detail. However, the relationship between SARS-CoV-2 and coagulation has been scarcely addressed. Our aim is to investigate the blood coagulation function of patients with SARS-CoV-2 infection. Methods In our study, 94 patients with confirmed SARS-CoV-2 infection were admitted in Renmin Hospital of Wuhan University. We prospectively collect blood coagulation data in these patients and in 40 healthy controls during the same period. Results Antithrombin values in patients were lower than that in the control group (p < 0.001). The values of D-dimer, fibrin/fibrinogen degradation products (FDP), and fibrinogen (FIB) in all SARS-CoV-2 cases were substantially higher than those in healthy controls. Moreover, D-dimer and FDP values in patients with severe SARS-CoV-2 infection were higher than those in patients with milder forms. Compared with healthy controls, prothrombin time activity (PT-act) was lower in SARS-CoV-2 patients. Thrombin time in critical SARS-CoV-2 patients was also shorter than that in controls. Conclusions The coagulation function in patients with SARS-CoV-2 is significantly deranged compared with healthy people, but monitoring D-dimer and FDP values may be helpful for the early identification of severe cases.
  • |Adult[MESH]
  • |Anticoagulants[MESH]
  • |Betacoronavirus/pathogenicity[MESH]
  • |Biomarkers/blood[MESH]
  • |Blood Coagulation Tests/*methods[MESH]
  • |Blood Coagulation/*physiology[MESH]
  • |China/epidemiology[MESH]
  • |Coronavirus Infections/*blood/physiopathology[MESH]
  • |Disease Outbreaks[MESH]
  • |Female[MESH]
  • |Fibrin Fibrinogen Degradation Products/analysis[MESH]
  • |Fibrinogen/analysis[MESH]
  • |Humans[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Pandemics[MESH]
  • |Partial Thromboplastin Time[MESH]
  • |Pneumonia, Viral/*blood/physiopathology[MESH]
  • |Prothrombin/analysis[MESH]
  • |Severe Acute Respiratory Syndrome/epidemiology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    1116 7.58 2020